Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatric Hematology & Oncology Physician in San Diego, CA
NPI: 1346312964Primary Practice Location
RADY CHILDREN'S HOSPITAL - SAN DIEGO
3020 Childrens Way, San Diego, CA
Primary Employer
Rady Children's Specialists of San Diego, a Medical Foundation
rchsd.org
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2027
MA State Medical License
2005 - 2015
MN State Medical License
2003 - 2006
American Board of Pediatrics
Pediatrics
American Board of Pediatrics
Pediatric Hematology-Oncology
University Of Minnesota Medical School
med.umn.edu
Medical School
Until 1999
University of Minnesota
Fellowship • Pediatric Hematology/Oncology
2002 - 2005
Residency • Pediatrics
1999 - 2002
Irradiation‐free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromes
Authors: Deborah Schiff, Yunzu Wang, Nicholas Gloude
Publication Date: 2021-03
Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia.
Authors: Kasiani Myers, Jaap-Jan Boelens, Timothy Olson, Anant Vatsayan, Mary Eapen, Maria Cancio, Hasan Hashem, Lauri Burroughs, Farid Boulad
Journal: Transplant Cell Ther
Publication Date: 2021-10-17
Diagnosis and treatment of a boy with IPEX syndrome presenting with diabetes in early infancy.
Authors: Sejal Kadakia, David Dimmock, Ron Newfield
Journal: Clin Case Rep
Publication Date: 2019-09-27
Lead Sponsor: Center for International Blood and Marrow Transplant Research
Collaborators: University of Pittsburgh
Lead Sponsor: Center for International Blood and Marrow Transplant Research
Intervention / Treatment: DRUG: Busulfan, DEVICE: Cell processing for TCRαβ+/CD19+ depletion
Lead Sponsor: New York Blood Center
Intervention / Treatment: BIOLOGICAL: unlicensed CBU
